Evidence map›Paper›PMID 23460735›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

Staphylococcus aureus phenol-soluble modulin peptides modulate dendritic cell functions and increase in vitro priming of regulatory T cells.

Jens Schreiner, Dorothee Kretschmer, Juliane Klenk, Michael Otto, Hans-Jörg Bühring, Stefan Stevanovic, Ji Ming Wang, Sandra Beer-Hammer, Andreas Peschel, Stella E Autenrieth

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 66 citations in OpenAlex.

  1. Trial
  2. Article
  3. LinkingAntibiotics (Basel, Switzerland) · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Pharmacological Mechanisms of Shangke Huangshui against Skin and Soft Tissue Infection.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  10. Article
  11. Article
  12. Toxins · 2021
    Review
  13. Article
  14. Frontiers in immunology · 2020
    Article
  15. Frontiers in immunology · 2020
    Article
  16. Article
  17. mBio · 2019
    Article
  18. Article
  19. Article
  20. Frontiers in immunology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Jens SchreinerInterfaculty Institute for Cell Biology, Eberhard Karls University, 72076 Tübingen, Germany.
Dorothee Kretschmer
Juliane Klenk
Michael Otto
Hans-Jörg Bühring
Stefan Stevanovic
Ji Ming Wang
Sandra Beer-Hammer
Andreas Peschel
Stella E Autenrieth
University of Tübingen · DECenter for Cancer Research · USNational Institute of Allergy and Infectious Diseases · US

Funding

Staphylococcal pathogenesisZIAAI000904 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI OTTO, MICHAEL · 2009 to 2025
$22.6M
Role of Formylpeptide Receptors in Host DefenseZIABC010725 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WANG, JI MING · 2009 to 2023
$6.3M
Intramural NIH HHS ZIA AI000904NHLBI NIH HHS 5T32HL00778120PHS HHS 5T32A1078903-05PHS HHS AIR0147206PHS HHS K22A1081866
6 · The paper itself

Abstract

The major human pathogen Staphylococcus aureus has very efficient strategies to subvert the human immune system. Virulence of the emerging community-associated methicillin-resistant S. aureus depends on phenol-soluble modulin (PSM) peptide toxins, which are known to attract and lyse neutrophils. However, their influences on other immune cells remain elusive. In this study, we analyzed the impact of PSMs on dendritic cells (DCs) playing an essential role in linking innate and adaptive immunity. In human neutrophils, PSMs exert their function by binding to the formyl peptide receptor (FPR) 2. We show that mouse DCs express the FPR2 homolog mFPR2 as well as its paralog mFPR1 and that PSMs are chemoattractants for DCs at noncytotoxic concentrations. PSMs reduced clathrin-mediated endocytosis and inhibited TLR2 ligand-induced secretion of the proinflammatory cytokines TNF, IL-12, and IL-6, while inducing IL-10 secretion by DCs. As a consequence, treatment with PSMs impaired the capacity of DCs to induce activation and proliferation of CD4(+) T cells, characterized by reduced Th1 but increased frequency of FOXP3(+) regulatory T cells. These regulatory T cells secreted high amounts of IL-10, and their suppression capacity was dependent on IL-10 and TGF-β. Interestingly, the induction of tolerogenic DCs by PSMs appeared to be independent of mFPRs, as shown by experiments with mice lacking mFPR2 (mFPR2(-/-)) and the cognate G protein (p110γ(-/-)). Thus, PSMs from highly virulent pathogens affect DC functions, thereby modulating the adaptive immune response and probably increasing the tolerance toward the pathogen.

Indexed as

AnimalsBacterial ToxinsChemotaxisClathrinCytokinesDendritic CellsEndocytosisFemaleLymphocyte ActivationMicePeptidesReceptors, Formyl PeptideStaphylococcus aureusT-Lymphocytes, RegulatoryToll-Like Receptor 2Bacterial ToxinsClathrinCytokinesPeptidesReceptors, Formyl Peptidestaphylococcal delta toxinToll-Like Receptor 2

Identifiers

PMID23460735
PMCPMC3608756
OpenAlexW1952759707

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.